Beranda600664 • SHA
add
Harbin Pharmaceutical Group Co Ltd
Tutup sebelumnya
¥3,80
Rentang hari
¥3,66 - ¥3,76
Rentang tahun
¥2,41 - ¥4,97
Kapitalisasi pasar
9,97 M CNY
Volume Rata-Rata
111,33 jt
Rasio P/E
15,30
Hasil dividen
-
Bursa utama
SHA
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (CNY) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 4,11 M | 8,54% |
Biaya operasional | 833,10 jt | 0,85% |
Laba bersih | 164,90 jt | 52,98% |
Margin laba bersih | 4,01 | 41,20% |
Penghasilan per saham | — | — |
EBITDA | 318,87 jt | 26,26% |
Tarif pajak efektif | 23,46% | — |
Neraca
Total aset
Total liabilitas
| (CNY) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 3,13 M | 13,03% |
Total aset | 14,27 M | 2,51% |
Total liabilitas | 8,32 M | -3,45% |
Total ekuitas | 5,95 M | — |
Saham yang beredar | 2,52 M | — |
Harga terhadap nilai buku | 1,84 | — |
Tingkat pengembalian aset | 4,51% | — |
Tingkat pengembalian modal | 8,25% | — |
Arus Kas
Perubahan kas bersih
| (CNY) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 164,90 jt | 52,98% |
Kas dari operasi | 105,03 jt | -61,67% |
Kas dari investasi | -35,33 jt | 74,29% |
Kas dari pembiayaan | -173,45 jt | -5.358,43% |
Perubahan kas bersih | -104,01 jt | -174,49% |
Arus kas bebas | -77,99 jt | 22,01% |
Tentang
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Didirikan
1988
Situs
Karyawan
9.853
